Productive infection of primary murine astrocytes, lymphocytes, and macrophages by human immunodeficiency virus type 1 in culture

Journal of NeuroVirology

Volumn 10, Issue 6, 2004, Pages 400-408

  Nitkiewicz, Jadwiga ^a   Chao, Wei ^a   Bentsman, Galina ^a   Li, Jinliang ^a   Kim, Seon Young ^a   Choi, So Young ^a   Grunig, Gabrielle ^a   Gelbard, Harris ^b   Potash, Mary Jane ^a   Volsky, David J ^a  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

HIV 1; Mouse model; Pseudotype; Tropism

Indexed keywords

CYCLIN T1; GAG PROTEIN; PROTEINASE; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RNA SPLICING; SPLEEN LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; LYMPHOCYTES; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; NIH 3T3 CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, VIRAL; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

AMPHOTROPIC MURINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; MURINE LEUKEMIA VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 19944429433     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280490890097     Document Type: Article

References (42)

1. Aguilar-Cordova E, Chinen J, Donehower L, Lewis DE, Belmont JW (1994). A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res Hum Retrovir 10: 295-301.
2. Benos DJ, Hahn BH, Bubien JK, Ghosh SK, Mashburn NA, Chaikin MA, Shaw GM, Benveniste EN (1994). Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc Natl Acad Sci U S A 91: 494-498.
3. Bieniasz PD, Cullen BR (2000). Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol 74: 9868-9877.
4. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB (1988). Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642.
5. Browning J, Horner JW, Pettoello-Mantovani M, Raker C, Yurasov S, DePinho RA, Goldstein H (1997). Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci U S A 94: 14637-14641.
6. Browning Paul J, Wang EJ, Pettoello-Mantovani M, Raker C, Yurasov S, Goldstein MM, Horner JW, Chan J, Goldstein H (2000). Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia: a new in vivo system for studying the postintegration phase of HIV replication. AIDS Res Hum Retrovir 16: 481-492.
7. Canki M, Thai JNF, Chao W, Ghorpade A, Potash MJ, Volsky DJ (2001). Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J Virol 75: 7925-7933.
8. Chackerian B, Long EM, Luciw PA, Overbaugh J (1997). HIV-1 co-receptors participates in post entry stages of virus replication cycle and function in SIV infection. J Virol 71: 3932-3939.
9. Doherty TM, Chougnet C, Schito M, Patterson BK, Fox C, Shearer GM, Englund G, Sher A (1999). Infection of HIV-1 transgenic mice with Mycobacterium avium induces the expression of infectious virus selectively from a Mac-1-positive host cell population. J Immunol 163: 1506-1515.
10. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA (1990). HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364-367.
11. Fedoroff S, Richardson A (2001). Protocols for Neural Cell Culture, 3rd ed. Totowa, NJ: Humana Press.
12. Hanna Z, Kay DG, Cool M, Jothy S, Rebai N, Jolicoeur P (1998a). Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J Virol 72: 121-132.
13. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P (1998b). Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95: 163-175.
14. Hatziioannou T, Cowan S, Bieniasz PD (2004). Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells. J Virol 78: 1006-1011.
15. Ho DD, Moudgil T, Alam M (1989). Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 321: 1621-1625.
16. + T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc Natl Acad Sci U S A 98: 658-663.
17. Jolicoeur P (1979). The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr Top Microbiol Immunol 86: 67-122.
18. Keppler OT, Welte FJ, Ngo TA, Chin PS, Patton KS, Tsou C-L, Abbey NW, Sharkey ME, Grant RM, You Y, Scarborough JD, Ellmeier W, Littman DR, Stevenson M, Charo, IF, Herndier BG, Speck RF, Goldsmith MA (2002). Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J Exp Med 195: 719-736.
19. Keppler OT, Yonemoto W, Welte FJ, Patton KS, Iacovides D, Atchison RE, Ngo T, Hirschberg DL, Speck RF, Goldsmith MA (2001). Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J Virol 75: 8063-8073.
20. Kim S-Y, Chao W, Choi S-Y, Volsky DJ (2003). Cloning and characterization of the 3′-untranslated region of the human excitatory amino acid transporter 2 transcript. J Neurochem 86: 1458-1467.
21. Kimpton J, Emerman M (1992). Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 66: 2232-2239.
22. Klotman EM, Kim S, Buchbinder A, DeRossi A, Baltimore D, Wong-Staal F (1991). Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A 88: 5011-5015.
23. Koito A, Shigekane H, Matsushita S (2003). Ability of small animal cells to support the postintegration phase of human immunodeficiency virus type-1 replication. Virology 305: 181-191.
24. Kwak YT, Ivanov D, Guo J, Nee E, Gaynor RB (1999). Role of the human and murine cyclin T proteins in regulating HIV-1 tat activation. J Mol Biol 288: 57-69.
25. Lee S, Lapham CK, Chen H, King L, Manischewitz J, Romantseva T, Mostowski H, Stantchev TS, Broder CC, Golding H (2000). Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 74: 5016-5023.
26. Levy JA, Cheng-Mayer C, Dina D, Luciw PA (1986). AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science 232: 998-1001.
27. Ludwig E, Ceccherini-Silberstein F, van Empel J, Erfle V, Neumann M, Brack-Werner R (1999). Diminished Rev-mediated stimulation of human immunodeficiency virus type 1 is a hallmark of human astrocytes. J Virol 73: 8279-8289.
28. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986). The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47: 333-348.
29. Mariani R, Rutter G, Harris ME, Hope TJ, Krausslich HG, Landau NR (2000). A block to human immunodeficiency virus type 1 assembly in murine cells. J Virol 74: 3859-3870.
30. Merrill JE, Koyanagi Y, Zack JA, Thomas L, Martin F, Chen I (1992). Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 66: 2217-2225.
31. Mitsuya H, Broder S (1986). Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc Natl Acad Sci U S A 83: 1911-1915.
32. Mizrachi Y, Sternas L, Volsky DJ (1992). The establishment of rodent cell lines persistently producing HIV-1. Virology 186: 167-174.
33. Narayan O, Wolinsky JS, Clements JE, Strandberg JD, Griffin DE, Cork LC (1982). Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol 59: 345-356.
34. Orenstein JM, Meltzer MS, Phipps T, Gendelman HE (1988). Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 62: 2578-2586.
35. Page KA, Landau NR, Littman DR (1990). Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J Virol 64: 5270-5276.
36. + T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors. J Exp Med 187: 1439-1449.
37. Towers G, Bock M, Martin S, Takeuchi Y, Stoye JP, Danos O (2000). A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci U S A 97: 12295-12299.
38. Tuttle DL, Harrison JK, Anders C, Sleasman JW, Goodenow MM (1998). Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 72: 4962-4969.
39. Westervelt P, Gendelman HE, Ratner L (1991). Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc Natl Acad Sci U S A 88: 3097-3101.
40. Winslow BJ, Trono D (1993). The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent. J Virol 67: 2349-2354.
41. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, Mackay CR (1997). CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 185: 1681-1691.
42. Zheng YH, Yu HF, Peterlin BM (2003). Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nat Cell Biol 5: 611-618.